fda warning letters compounding semaglutide october 2025 Beyond the Headlines: to GLP-1 Compounders Drugmakers battle pharmacies over compounded

Any significant change from baselineparticularly the development of bloody stools, nocturnal diarrhea awakening them from sleep, or progressive worsening of symptomswarrants prompt clinical assessment

Drug Metab Rev 31:1528

Berthon BS, Wood LG

Reciprocally, populations that are prone to obesity have been shown to have an inherently elevated desire for sweet diets

Clinical research has shown that, when combined with a reduced-calorie diet and increased physical activity, semaglutide can lead to significant weight loss

Cons: Prices can fluctuate frequently, and the lowest-cost pharmacies may not always be convenient or covered by insurance